Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial

By News Health
2 months Ago

(MedPage Today) — SAN FRANCISCO — For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement (TMVR).
Following the…

Source link : https://www.medpagetoday.com/meetingcoverage/tct/118208

Author :

Publish date : 2025-10-29 16:42:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Tirzepatide Matches Competitor's Cardioprotective Benefits for Diabetics

Gout and Its Comorbidities

Combination Model May Improve Diagnosis of Serious Respiratory Infections

High-Fat Cheese May Have Cognitive Benefit, Study Suggests

Four Republicans Defy House Speaker to Force Vote on Extending ACA Subsidies

Two Extended-Release Buprenorphine Doses Effective in High-Risk Opioid Use Disorder